‘Glaring Gap’ Seen in DNA Privacy Pledges by 23andMe, Ancestry
By Kristen V Brown,
Bloomberg
| 08. 02. 2018
Genetic-testing companies that have decoded the DNA of millions just introduced new guidelines to protect data privacy.
But those best practices failed to address a major concern: what happens to customers’ data that is shared for research with pharmaceutical giants, academics and others, often for a profit.
Just how lucrative the business of genetic testing is came into light last week when British drugmaker GlaxoSmithKline Plc agreed to buy a $300 million stake in 23andMe Inc., gaining access to anonymized data with the hope of identifying new targets for drugs. That kind of data -- stripped of identifying details and aggregated -- isn’t strictly subject to new rules in the guidelines unveiled this week. That means consumers will still have little way to know when and how their information is combed for research.
“This new policy is a positive step forward in the sense that it’s starting a conversation,” said James Hazel, a researcher at Vanderbilt University in Nashville, Tennessee, who recently surveyed the privacy policies of 90 direct-to-consumer genetic-testing companies. “The glaring gap is that it doesn’t apply...
Related Articles
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Katherine Drabiak, Journal of Medical Ethics Forum | 08.07.2025
Adapted from Mitochondrial DNA at
National Human Genome Research Institute
Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center...
By Nicky Hudson, The Conversation | 08.12.2025